-
Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…
-
Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…
-
How Peer Mentors Help Patients Start and Stay on Therapy in Rare Disease
In rare disease, a missing piece in starting and staying on therapy is often lived perspective. Patients and their care partners may begin rare disease treatment with no peer reference…
-
Six Patient Engagement “Trends” We Should Have Outgrown by 2026
By Cheryl Lubbert, Reverba Global CEO. A New-Year Perspective on Patient Engagement The biopharma industry talks a good game about patient engagement. We talk about personalization, digital transformation, empowerment, omnichannel…
-
Elevating Voices, Empowering Futures: Mentorship as a Catalyst for Change in Biopharma
By Cheryl Lubbert, Reverba Global CEO. In biopharma, where innovation depends on both scientific discovery and human connection, mentorship stands as one of the most powerful forces for progress. It’s…
-
Bridging Science and Strategy: Medical Affairs at the Heart of Omnichannel Engagement
In this video podcast hosted by Pharmaphorum, Editor in Chief Jonah Comstock speaks with Cheryl Lubbert, co-founder and CEO of Reverba Global, and Carolyn Whiting, SVP of Clinical and Medical…
-
Turning Data into Dialogue: How Numbers Build Trust Between Patients and Clinicians
By Cheryl Lubbert, CEO of Reverba Global In healthcare, every word matters – but the way we communicate those words, and the numbers behind them, is changing. For patients to…
-
Closing the Gap: Why Patient Engagement Can’t Wait
Key Takeaways For all the progress in modern healthcare—from electronic records to AI-driven insights—a critical question remains: Why do so many people still feel unheard in their own care? Innovation…
-
Highlights from HBA: Collaboration Is the New Competitive Advantage
At this year’s Healthcare Businesswomen’s Association (HBA) Annual Conference, one message resonated across every room: no one can tackle systemic inequities alone. And this conference provides tools to work together…
-
Beyond the Algorithm: What HLTH 2025 Showed Us About the Future of Human-Centered Innovation
The pulse of HLTH 2025 At this year’s HLTH USA conference in Las Vegas, the conversation was louder—and more human—than ever. Thousands of leaders from pharma, biotech, technology, and care…
-
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company demonstratedmeasurable and significant…
-
Reverba Unveils Updated Brand Identity as Reverba Global™, Reflecting the Company’s Expansion and Global Capabilities as a Leader in Healthcare Engagement
Seattle, WA – April 07, 2025 – Reverba, a leader in healthcare engagement, today announced its rebranding as Reverba Global in response to accelerated company growth and international scope. At…
